Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Nitric Oxide
100%
Staphylococcus Aureus
93%
Antiinfective Agent
83%
Skin Infection
50%
Methicillin-Resistant Staphylococcus Aureus
47%
Infection
46%
Wound Infection
35%
Meticillin
33%
Vancomycin
32%
Mixed Infection
30%
Pseudomonas aeruginosa
29%
Sustained Release
27%
S Nitrosoglutathione
26%
Abscess
26%
Daptomycin
25%
Panton-Valentine Leukocidin
25%
Antibiotics
25%
Staphylococcal Bacteremia
25%
Elimination
25%
Device Infection
25%
Oropharynx Candidiasis
25%
Matrix-Assisted Laser Desorption/Ionization
25%
Caspofungin
25%
Mycosis
25%
Fluconazole
25%
Hydrazone Derivative
25%
Febrile Neutropenia
25%
Methicillin Susceptible Staphylococcus Aureus
25%
Candiduria
25%
Methicillin Resistant Staphylococcus Aureus Infection
23%
Wound
19%
Microorganism
12%
Antimicrobial Resistance
11%
Antibiotic Agent
10%
IC50
9%
Bacteremia
8%
Penicillinase
8%
Inflammation
8%
Soft Tissue Infection
7%
Murine
6%
Enterococcus
6%
Staphylococcal Infection
6%
Infectious Agent
6%
Multiple Drug Resistance
5%
Loss of Appetite
5%
Skin Injury
5%
Biological Activity
5%
Disease
5%
Candida Albicans
5%
Keyphrases
Staphylococcus Aureus
50%
Skin Infection Models
25%
Positive Blood Culture
25%
Murine Skin
25%
Intramuscular Abscess
25%
Oxide Nanoparticles
25%
Antibiofilm
25%
Epidemiology
25%
Nitro
25%
Metabolism
25%
BACTEC
25%
Subculture
25%
Clonal Complex
25%
Agglutination Assay
25%
Rapid Detection
25%
Resistance Mechanisms
25%
Absorption Distribution
25%
Endotoxin Level
25%
Baumannii
25%
Fungal Co-infections
25%
Matrix-assisted Laser Desorption Ionization-time of Flight Mass Spectrometry (MALDI-TOF MS)
25%
Recurrent Bacteremia
25%
Abiotic Surfaces
25%
Rapid Detection Method
25%
Antimicrobial Properties
25%
Maggots
25%
Oropharyngeal Candidiasis
25%
Community-acquired Infections
25%
Staphylococcus Aureus Bacteremia
25%
Immunocompromised Adults
25%
Paecilomyces
25%
Healing Efficacy
25%
Antibiotic Use
25%
Chryseobacterium
25%
Fungal Infection
25%
Chryseobacterium Indologenes
25%
Oropharyngeal
25%
In Vitro Antibacterial Activity
25%
Nongrowing
25%
Daptomycin Nonsusceptibility
25%
Methylidene
25%
Stewardship
25%
Fluconazole
25%
Negative Bacteria
25%
Multidisciplinary Tools
25%
Synthetic Mimics of Antimicrobial Peptides (SMAMPs)
25%
First Day
25%
Butyricimonas
25%
Vancomycin
25%
Febrile Neutropenia
25%
Immunology and Microbiology
Escherichia coli
79%
Staphylococcus Aureus
75%
Methicillin-Resistant Staphylococcus Aureus
62%
Pseudomonas aeruginosa
50%
Secretion (Process)
50%
Klebsiella pneumoniae
37%
Antimicrobial Peptides
30%
Soft Tissue
28%
Abscess
28%
Acinetobacter Baumannii
25%
Methicillin Susceptible Staphylococcus Aureus
25%
Human Respiratory Syncytial Virus
25%
Coagulase Negative Staphylococcus
25%
Candida Albicans
25%
Candida Parapsilosis
25%
Antimicrobial Activity
25%
Antimicrobial Resistance
25%
Microorganism
25%
Time-of-Flight Mass Spectrometry
25%
Matrix-Assisted Laser Desorption-Ionization
25%
Murine
25%
Chryseobacterium indologenes
25%
Chryseobacterium
25%
Pharmacodynamics
25%
Enterotoxin
25%
Streptococcus pyogenes
25%
Enterococcus faecalis
25%
Drug Interaction
25%
COVID-19
25%
Bactericidal Activity
25%
Coinfection
25%
Peritonitis
25%
Streptococcus Agalactiae
25%
Tumor Necrosis Factor Alpha
25%
Candida Glabrata
25%
Host Resistance
16%
Sustained Drug Release
12%
Monospecific Antibody
12%
Monocyte
12%
Gram-Negative Bacteria
12%
Cell Death
12%
Bacterial Strain
12%
Gelation
12%
Cell Membrane
12%
Cell Lysate
12%
Limulus
12%
Mouse
12%
Polymerase Chain Reaction
10%
Cloaca
8%
MacConkey Agar
8%